Cargando…
Rare Benign Tumors of the Liver: Still Rare?
BACKGROUND: Benign liver tumors are common. They do not spread to other areas of the body, and they usually do not pose a serious health risk. In fact, in most cases, benign liver tumors are not diagnosed because patients are asymptomatic. When they are detected, it’s usually because the person has...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101630/ https://www.ncbi.nlm.nih.gov/pubmed/24510731 http://dx.doi.org/10.1007/s12029-014-9580-4 |
_version_ | 1783511664351510528 |
---|---|
author | Bertino, Gaetano Ardiri, Annalisa Demma, Shirin GiuseppeCalvagno, Stefano Toro, Adriana Basile, Elisa Campagna, Davide Ferraro, Giorgia Frazzetto, Evelise Proiti, Maria Malaguarnera, Giulia Bertino, Nicoletta Malaguarnera, Mariano Malaguarnera, Michele Amaradio, Maria Domenica Pricoco, Gabriele Di Carlo, Isidoro |
author_facet | Bertino, Gaetano Ardiri, Annalisa Demma, Shirin GiuseppeCalvagno, Stefano Toro, Adriana Basile, Elisa Campagna, Davide Ferraro, Giorgia Frazzetto, Evelise Proiti, Maria Malaguarnera, Giulia Bertino, Nicoletta Malaguarnera, Mariano Malaguarnera, Michele Amaradio, Maria Domenica Pricoco, Gabriele Di Carlo, Isidoro |
author_sort | Bertino, Gaetano |
collection | PubMed |
description | BACKGROUND: Benign liver tumors are common. They do not spread to other areas of the body, and they usually do not pose a serious health risk. In fact, in most cases, benign liver tumors are not diagnosed because patients are asymptomatic. When they are detected, it’s usually because the person has had medical imaging tests, such as an ultrasound (US), computed tomography (CT) scan, or magnetic resonance imaging (MRI), for another condition. MATERIALS AND METHODS: A search of the literature was made using cancer literature and the PubMed, Scopus, and Web of Science (WOS) database for the following keywords: “hepatic benign tumors”, “hepatic cystic tumors”, “polycystic liver disease”, “liver macroregenerative nodules”, “hepatic mesenchymal hamartoma”, “hepatic angiomyolipoma”, “biliary cystadenoma”, and “nodular regenerative hyperplasia”. DISCUSSION AND CONCLUSION: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some areas of the world; there is an increasing incidence worldwide. Approximately 750,000 new cases are reported per year. More than 75 % of cases occur in the Asia-Pacific region, largely in association with chronic hepatitis B virus (HBV) infection. The incidence of HCC is increasing in the USA and Europe because of the increased incidence of hepatitis C virus (HCV) infection. Unlike the liver HCC, benign tumors are less frequent. However, they represent a chapter always more interesting of liver disease. In fact, a careful differential diagnosis with the forms of malignant tumor is often required in such a way so as to direct the patient to the correct therapy. In conclusion, many of these tumors present with typical features in various imaging studies. On occasions, biopsies are required, and/or surgical removal is needed. In the majority of cases of benign hepatic tumors, no treatment is indicated. The main indication for treatment is the presence of significant clinical symptoms or suspicion of malignancy or fear of malignant transformation. |
format | Online Article Text |
id | pubmed-7101630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-71016302020-03-31 Rare Benign Tumors of the Liver: Still Rare? Bertino, Gaetano Ardiri, Annalisa Demma, Shirin GiuseppeCalvagno, Stefano Toro, Adriana Basile, Elisa Campagna, Davide Ferraro, Giorgia Frazzetto, Evelise Proiti, Maria Malaguarnera, Giulia Bertino, Nicoletta Malaguarnera, Mariano Malaguarnera, Michele Amaradio, Maria Domenica Pricoco, Gabriele Di Carlo, Isidoro J Gastrointest Cancer Invited Reviews BACKGROUND: Benign liver tumors are common. They do not spread to other areas of the body, and they usually do not pose a serious health risk. In fact, in most cases, benign liver tumors are not diagnosed because patients are asymptomatic. When they are detected, it’s usually because the person has had medical imaging tests, such as an ultrasound (US), computed tomography (CT) scan, or magnetic resonance imaging (MRI), for another condition. MATERIALS AND METHODS: A search of the literature was made using cancer literature and the PubMed, Scopus, and Web of Science (WOS) database for the following keywords: “hepatic benign tumors”, “hepatic cystic tumors”, “polycystic liver disease”, “liver macroregenerative nodules”, “hepatic mesenchymal hamartoma”, “hepatic angiomyolipoma”, “biliary cystadenoma”, and “nodular regenerative hyperplasia”. DISCUSSION AND CONCLUSION: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some areas of the world; there is an increasing incidence worldwide. Approximately 750,000 new cases are reported per year. More than 75 % of cases occur in the Asia-Pacific region, largely in association with chronic hepatitis B virus (HBV) infection. The incidence of HCC is increasing in the USA and Europe because of the increased incidence of hepatitis C virus (HCV) infection. Unlike the liver HCC, benign tumors are less frequent. However, they represent a chapter always more interesting of liver disease. In fact, a careful differential diagnosis with the forms of malignant tumor is often required in such a way so as to direct the patient to the correct therapy. In conclusion, many of these tumors present with typical features in various imaging studies. On occasions, biopsies are required, and/or surgical removal is needed. In the majority of cases of benign hepatic tumors, no treatment is indicated. The main indication for treatment is the presence of significant clinical symptoms or suspicion of malignancy or fear of malignant transformation. Springer US 2014-02-09 2014 /pmc/articles/PMC7101630/ /pubmed/24510731 http://dx.doi.org/10.1007/s12029-014-9580-4 Text en © Springer Science+Business Media New York 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Invited Reviews Bertino, Gaetano Ardiri, Annalisa Demma, Shirin GiuseppeCalvagno, Stefano Toro, Adriana Basile, Elisa Campagna, Davide Ferraro, Giorgia Frazzetto, Evelise Proiti, Maria Malaguarnera, Giulia Bertino, Nicoletta Malaguarnera, Mariano Malaguarnera, Michele Amaradio, Maria Domenica Pricoco, Gabriele Di Carlo, Isidoro Rare Benign Tumors of the Liver: Still Rare? |
title | Rare Benign Tumors of the Liver: Still Rare? |
title_full | Rare Benign Tumors of the Liver: Still Rare? |
title_fullStr | Rare Benign Tumors of the Liver: Still Rare? |
title_full_unstemmed | Rare Benign Tumors of the Liver: Still Rare? |
title_short | Rare Benign Tumors of the Liver: Still Rare? |
title_sort | rare benign tumors of the liver: still rare? |
topic | Invited Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101630/ https://www.ncbi.nlm.nih.gov/pubmed/24510731 http://dx.doi.org/10.1007/s12029-014-9580-4 |
work_keys_str_mv | AT bertinogaetano rarebenigntumorsoftheliverstillrare AT ardiriannalisa rarebenigntumorsoftheliverstillrare AT demmashirin rarebenigntumorsoftheliverstillrare AT giuseppecalvagnostefano rarebenigntumorsoftheliverstillrare AT toroadriana rarebenigntumorsoftheliverstillrare AT basileelisa rarebenigntumorsoftheliverstillrare AT campagnadavide rarebenigntumorsoftheliverstillrare AT ferrarogiorgia rarebenigntumorsoftheliverstillrare AT frazzettoevelise rarebenigntumorsoftheliverstillrare AT proitimaria rarebenigntumorsoftheliverstillrare AT malaguarneragiulia rarebenigntumorsoftheliverstillrare AT bertinonicoletta rarebenigntumorsoftheliverstillrare AT malaguarneramariano rarebenigntumorsoftheliverstillrare AT malaguarneramichele rarebenigntumorsoftheliverstillrare AT amaradiomariadomenica rarebenigntumorsoftheliverstillrare AT pricocogabriele rarebenigntumorsoftheliverstillrare AT dicarloisidoro rarebenigntumorsoftheliverstillrare |